Myanmar vs Namibia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Myanmar
1.3%
in 2024
Namibia
1.1%
in 2024
Myanmar rank
24th
Namibia rank
26th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Myanmar
- Namibia
How they compare
Myanmar currently reports 1.3% against 1.1% in Namibia, a difference of 0.2%.
That makes Myanmar's figure about 1.2 times Namibia's.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Myanmar ahead.
Myanmar ranks 24th and Namibia ranks 26th of 215 countries.
Namibia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Myanmar | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.3% | 1.4% | 0.1% | Namibia |
| 2020s | 1.1% | 1.2% | 0.1% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Myanmar or Namibia?
- Myanmar, at 1.3% against 1.1% in Namibia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Myanmar and Namibia?
- 0.2%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Namibia?
- 10 years are reported by both, from 2015 to 2024.
- How do Myanmar and Namibia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Myanmar ranks 24th and Namibia ranks 26th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.